HROW vs. CAVA
HROW (Harrow Health, Inc.) and CAVA (CAVA Group Inc.) are both stocks. HROW operates in Drug Manufacturers - Specialty & Generic (Healthcare), while CAVA operates in Restaurants (Consumer Cyclical). Over the past 3 years, HROW returned 23.37%/yr vs 6.45%/yr for CAVA. Their 0.24 correlation means their historical movements had little consistent relationship.
Performance
HROW vs. CAVA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HROW achieves a -20.22% return, which is significantly lower than CAVA's 9.85% return.
HROW
- 1D
- 0.83%
- 1M
- -8.54%
- 6M
- -12.94%
- YTD
- -20.22%
- 1Y
- 25.17%
- 3Y*
- 23.37%
- 5Y*
- 33.41%
- 10Y*
- 25.76%
- ALL TIME*
- -5.76%
CAVA
- 1D
- -1.17%
- 1M
- -16.14%
- 6M
- 8.17%
- YTD
- 9.85%
- 1Y
- -23.52%
- 3Y*
- 6.45%
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 14.65%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
CAVA CAVA Group Inc. | $230.01M | $227.24M | $254.44M |
| $19.20M | $23.84M | $30.84M |
HROW vs. CAVA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
HROW Harrow Health, Inc. | -20.22% | 46.05% | 199.55% | -42.56% |
CAVA CAVA Group Inc. | 9.85% | -47.97% | 162.45% | 2.33% |
Correlation
The correlation between HROW and CAVA is 0.23, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.23 |
Correlation (3Y) Balances recent behavior with more history. | 0.27 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2023 | 0.24 |
Fundamentals
HROW:
$1.46B
CAVA:
$7.51B
HROW:
-$0.40
CAVA:
$0.54
HROW:
5.47
CAVA:
6.46
HROW:
$268.68M
CAVA:
$1.18B
HROW:
$199.11M
CAVA:
$216.81M
HROW:
$22.70M
CAVA:
$150.65M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HROW vs. CAVA — Risk / Return Rank
HROW
CAVA
HROW vs. CAVA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Harrow Health, Inc. (HROW) and CAVA Group Inc. (CAVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HROW | CAVA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +1.18 | ||
| Omega ratioGain probability vs. loss probability | 1.14 | 0.97 | +0.17 |
| Calmar ratioReturn relative to maximum drawdown | 0.54 | -0.46 | +1.00 |
| Martin ratioReturn relative to average drawdown | 1.10 | -0.89 | +1.99 |
Loading charts...
Drawdowns
HROW vs. CAVA - Drawdown Comparison
The maximum HROW drawdown since its inception was -99.46%, which is greater than CAVA's maximum drawdown of -71.11%. Use the drawdown chart below to compare losses from any high point for HROW and CAVA.
Loading charts...
Drawdown Indicators
| HROW | CAVA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.46% | -71.11% | -28.35% |
Max Drawdown (1Y)Largest decline over 1 year | -47.03% | -50.97% | +3.94% |
Max Drawdown (3Y)Largest decline over 3 years | -61.38% | -71.11% | +9.73% |
Max Drawdown (5Y)Largest decline over 5 years | -71.15% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -71.15% | — | — |
Current DrawdownCurrent decline from peak | -71.67% | -57.27% | -14.40% |
Average DrawdownAverage peak-to-trough decline | -86.58% | -31.05% | -55.53% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.96% | 26.50% | -3.54% |
Volatility
HROW vs. CAVA - Volatility Comparison
Harrow Health, Inc. (HROW) has a higher volatility of 16.31% compared to CAVA Group Inc. (CAVA) at 14.54%. This indicates that HROW's price experiences larger fluctuations and is considered to be riskier than CAVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HROW | CAVA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.31% | 14.54% | +1.77% |
Volatility (6M)Calculated over the trailing 6-month period | 54.79% | 44.66% | +10.13% |
Volatility (1Y)Calculated over the trailing 1-year period | 65.79% | 59.16% | +6.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 69.86% | 59.17% | +10.69% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.31% | 59.17% | +12.14% |
Dividends
HROW vs. CAVA - Dividend Comparison
Neither HROW nor CAVA has paid dividends to shareholders.
Financials
HROW vs. CAVA - Financials Comparison
This section allows you to compare key financial metrics between Harrow Health, Inc. and CAVA Group Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HROW vs. CAVA - Profitability Comparison
HROW - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Harrow Health, Inc. reported a gross profit of 27.05M and revenue of 44.20M. Therefore, the gross margin over that period was 61.2%.
CAVA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, CAVA Group Inc. reported a gross profit of 40.95M and revenue of 274.99M. Therefore, the gross margin over that period was 14.9%.
HROW - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Harrow Health, Inc. reported an operating income of -22.08M and revenue of 44.20M, resulting in an operating margin of -50.0%.
CAVA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, CAVA Group Inc. reported an operating income of 8.43M and revenue of 274.99M, resulting in an operating margin of 3.1%.
HROW - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Harrow Health, Inc. reported a net income of -27.60M and revenue of 44.20M, resulting in a net margin of -62.4%.
CAVA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, CAVA Group Inc. reported a net income of 4.92M and revenue of 274.99M, resulting in a net margin of 1.8%.
Frequently Asked Questions
HROW and CAVA have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HROW has higher volatility (16.31%) compared to CAVA (14.54%). In terms of maximum drawdown, HROW dropped -99.46% vs CAVA's -71.11%.
HROW currently has the higher Sharpe Ratio (0.39 vs -0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HROW and CAVA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer